Dr. Alan Sandler from the Oregon Health & Science University Discusses Immunotherapies for Lung Cancer
Alan Sandler, MD
Advertisement
Articles by Alan Sandler, MD
Dr. Alan Sandler, from the Oregon Health & Science University, Discusses the Tivantinib Mechanism of Action
Advertisement
Latest Updated Articles
Dr. Sandler Discusses the Tivantinib Mechanism of ActionPublished: June 25th 2012 | Updated:
Dr. Sandler on Immunotherapies to Treat Lung CancerPublished: August 2nd 2012 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Long-Term Cilta-Cel Data Show Low Rates of PFS Events in Standard-Risk R/R Myeloma
2
Real-World Data Support Clinical Benefit With Lifileucel in Previously Treated Advanced Melanoma
3
FDA Updates Axi-Cel Label to Remove Limitation of Use in R/R PCNSL
4
Dr Riedell on the Long-Term Efficacy of Tisa-Cel in R/R Follicular Lymphoma
5